FR2837102B1 - Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique - Google Patents

Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique

Info

Publication number
FR2837102B1
FR2837102B1 FR0203318A FR0203318A FR2837102B1 FR 2837102 B1 FR2837102 B1 FR 2837102B1 FR 0203318 A FR0203318 A FR 0203318A FR 0203318 A FR0203318 A FR 0203318A FR 2837102 B1 FR2837102 B1 FR 2837102B1
Authority
FR
France
Prior art keywords
antiherpetic
medicament
manufacture
manufacturing
gel composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0203318A
Other languages
English (en)
Other versions
FR2837102A1 (fr
Inventor
Didier Paluszezak
Andre Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PALBIAN SNC
Original Assignee
PALBIAN SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PALBIAN SNC filed Critical PALBIAN SNC
Priority to FR0203318A priority Critical patent/FR2837102B1/fr
Priority to AU2003227847A priority patent/AU2003227847A1/en
Priority to PCT/FR2003/000862 priority patent/WO2003077922A1/fr
Publication of FR2837102A1 publication Critical patent/FR2837102A1/fr
Application granted granted Critical
Publication of FR2837102B1 publication Critical patent/FR2837102B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0203318A 2002-03-18 2002-03-18 Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique Expired - Fee Related FR2837102B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0203318A FR2837102B1 (fr) 2002-03-18 2002-03-18 Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
AU2003227847A AU2003227847A1 (en) 2002-03-18 2003-03-18 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament
PCT/FR2003/000862 WO2003077922A1 (fr) 2002-03-18 2003-03-18 Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notament antiherpetique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203318A FR2837102B1 (fr) 2002-03-18 2002-03-18 Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique

Publications (2)

Publication Number Publication Date
FR2837102A1 FR2837102A1 (fr) 2003-09-19
FR2837102B1 true FR2837102B1 (fr) 2004-10-08

Family

ID=27772205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203318A Expired - Fee Related FR2837102B1 (fr) 2002-03-18 2002-03-18 Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique

Country Status (3)

Country Link
AU (1) AU2003227847A1 (fr)
FR (1) FR2837102B1 (fr)
WO (1) WO2003077922A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2562190C (fr) * 2004-04-05 2012-08-21 Laboratorios Liomont, S.A. De C.V. Nouvelle presentation d'une composition pharmaceutique antivirale
TWI418347B (zh) * 2009-10-21 2013-12-11 Yung Shin Pharm Ind Co Ltd 治療疱疹病毒感染的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0551626A1 (fr) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Gel thermoréversible utile comme excipient pharmaceutique pour une formation galénique
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
DE4425322A1 (de) * 1994-07-18 1996-01-25 Merck Patent Gmbh Virostatika in hydrophober Gelgrundlage
WO1996020712A1 (fr) * 1994-12-30 1996-07-11 American Home Products Corporation Solutions transparentes d'hydrocortisone exemptes d'alcools
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
WO1997034607A1 (fr) * 1996-03-20 1997-09-25 Glaxo Group Limited Formulations d'aciclovir a usage local
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
AU2003227847A1 (en) 2003-09-29
FR2837102A1 (fr) 2003-09-19
WO2003077922A1 (fr) 2003-09-25

Similar Documents

Publication Publication Date Title
DZ3478A1 (fr) Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.
ATE322269T1 (de) Aripiprazole wirkstoff mit niedriger hygroskopie und verfahren zu ihrer herstellung
FR15C0090I2 (fr) Solutions et procede d'irrigation ophtalmologique
ITRM20020264A0 (it) Articolo assorbente e procedimento per la sua fabbricazione.
ITRM20000228A0 (it) Scidula multistrato e procedimento per la sua produzione.
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
AU2003220982A8 (en) Reduced striae extreme ultraviolegt lithographic elements, a method of manufacturing the same and a method of measuring striae
FR2804959B1 (fr) Utilisation de derives de paullones pour la fabrication de medicaments
AU2003245243A1 (en) Face mask and method of manufacturing the same
CY2009017I2 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
DE60221238D1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
ID26478A (id) Penggambaran kelima macam langkah produksi
DE69941825D1 (de) Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
AU2002366260A1 (en) Structured surfaces having elevations and depressions, method for producing surfaces of this type and the use thereof
IS2724B (is) 5-hluta heteróhringir, framleiðsla og notkun þeirra sem lyfja
FR2837102B1 (fr) Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ITRM20010048A0 (it) Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
FI19992142A (fi) Vesineulattu kuitukangas, menetelmä sen valmistamiseksi ja sen käyttö
IT1319139B1 (it) Procedimento per la fabbricazione di fucinati a stampo estesi inlunghezza
ITTO20000467A0 (it) Procedimento e macchina per la realizzazione di piastre per accumulatori.
ITRM20010332A0 (it) Vaccini a subunita' e procedimenti per la loro produzione.
FI20010730A (fi) Menetelmä hoitotuotteen valmistamiseksi ja hoitotuote
AU2002366793A1 (en) Improved lilly of the valley aromachemicals
IL162562A (en) Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines
FR2837708B1 (fr) Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121130